12 weeks, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of ME315 (Morus alba extract) on serum cholesterol

12 weeks, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of ME315 (Morus alba extract) on serum cholesterol

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002108

Enrollment

Registered

2016-10-18

Start date

2015-01-21

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Subjects will orally self-adminster Morus alba extract tablet 1,500mg or placebo bid, 4 tablets per day for 12weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Total Cholesterol 170~250 mg/dl or LDL-Cholesterol 130~189 (20yrs~60yrs)

Exclusion criteria

Exclusion criteria: Subjects who has taken medicines, health functional foods within 3 months for improvement of Cholesterol level.

Design outcomes

Primary

Measure	Time frame
Total cholesterol ;LDL-cholesterol ;HDL- cholesterol	—

Secondary

Measure	Time frame
Adverse Event	—

Countries

Korea, Republic of

Contacts

Public ContactKang Heon

Inje University Seoul Paik Hospital

fmleader@nuri.net

Outcome results